Szpital Czerniakowski Sp. z o.o.

Warsaw 10 trials 6 recruiting

10 Registered trials

6 Currently recruiting

Organisation

Szpital Czerniakowski Sp. z o.o.

Location

Warsaw, Poland

Identifier

ORG-100047510

Address

Ul. Ulica Stepinska 19/25, 00-739, Poland

Departments

-
N/A
Neurology with Stroke Unit
Oddział Chorób Wewnętrznych
Oddział Chorób Wewnętrznych, Endokrynologii, Diabetologii, Nefrologii, Chorób Metabolicznych
Oddział Neurologiczny

Clinical trials at this site (10)

Search interface

Supporting weak immune system during autoimmune therapy: testing Panzyga to prevent infections Pending

2025-522854-37-00 Prevention of a Major infection in patients with Hypoga 5
A study to learn if DM199 drug is safe and whether it works better than placebo for treating acute ischemic stroke Recruiting

2024-513911-28-00 Acute Ischemic Stroke 10 2026-03-04
Dose-Selection, Safety and Efficacy Study with Open-Label Extension of Choline Chloride for Injection in Adolescent and Adult Patients with … Recruiting

2024-519496-26-00 Intestinal Failure 10 2025-09-25
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) Recruiting

2025-522674-36-00 Metabolic Dysfunction-Associated Steatotic Liver Diseas 5 2026-03-24
A randomized, phase 3 multicenter study to confirm the clinical efficacy of linaprazan glurate compared to lansoprazole in participants with… Recruiting

2024-518714-31-00 Erosive esophagitis (EE) due to gastroesophageal reflux 5 2025-10-03
A Study of LY3457263 Compared to Placebo in Participants with Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide Recruiting

2024-520328-27-00 Type 2 Diabetes 4 2025-08-07
A Trial of Lu AG13909 in Adult Participants with Cushing’s Disease Recruiting

2023-504733-53-00 Cushing's Disease 4 2024-09-26
REDEFINE 3: A research study to see the effects of CagriSema in people living with diseases in the heart and blood vessels Ended

2023-506924-94-00 Cardiovascular disease 5 2023-02-28
A Phase 3 study to assess efficacy and safety of oral tebipenem compared to IV imipenem-cilastatin in adults with cUTI/AP Ended

2023-503785-22-00 complicated urinary tract infection (cUTI) or acute pye 5 2024-03-25
A randomized, phase 3 multicenter clinical trial to confirm the clinical efficacy and evaluate the safety of linaprazan glurate compared to … Ended

2025-522750-39-00 Erosive esophagitis (EE) due to gastroesophageal reflux 5